Efficacy and Safety of Kleeb Bua Daeng Formula in Mild Cognitive Impairment Patients: A Phase I Randomized, Double-Blind, Placebo-Controlled Trial

Table 1

Baseline characteristics of the KBD clinical trial in general.

	KBD	Placebo	value
Male (%)	5 (25)	4 (20)	1.000
Female (%)	15 (75)	16 (80)
Mean age ± SD (years)	58.30 ± 5.68	58.35 ± 6.65	0.980
Min	47	41
Max	70	70
Baseline blood pressure (mmHg)
Systolic (mean ± SD)	129.25 ± 19.94	132.45 ± 17.30	0.5909
Min	103	100
Max	163	174
Diastolic (mean ± SD)	77.95 ± 11.01	75.40 ± 14.35	0.5322
Min	60	48
Max	99	106
BMI (mean ± SD)	24.06 ± 2.85	24.92 ± 5.23	0.5212
Min	17.76	16.06
Max	29.97	32.98